...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: CKD or CD,... or both
4
Oct 07, 2019 05:40PM

I agree that, from the available data we have from previous trials, the chance for seeing improvement in eGFR is better than an improvement in MOCA scores.  But I think that if RVX is going to soar in value, the MOCA data will be the driver....if eGFR data is all we have to hang our hat on, maybe we'll get back to where we were, maybe $3 to $4....that's my take right now but its just a guess.

4
Oct 07, 2019 06:20PM
1
Oct 07, 2019 06:22PM
4
Oct 08, 2019 02:34AM
3
Oct 08, 2019 04:13AM
7
Oct 08, 2019 08:58AM
3
Oct 08, 2019 09:45AM
Share
New Message
Please login to post a reply